ZVRA – zevra therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Zevra Therapeutics Files Preliminary Proxy
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) was given a new $18.00 price target on by analysts at JMP Securities.
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) had its price target raised by analysts at Canaccord Genuity Group Inc. from $23.00 to $25.00. They now have a "buy" rating on the stock.
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) had its price target raised by analysts at Guggenheim from $20.00 to $22.00. They now have a "buy" rating on the stock.
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Form 4 ZEVRA THERAPEUTICS, INC. For: Mar 28 Filed by: Watton Corey Michael
Form DEFA14A ZEVRA THERAPEUTICS, INC.
Form DEFA14A ZEVRA THERAPEUTICS, INC.
Form PREC14A ZEVRA THERAPEUTICS, INC. Filed by: ZEVRA THERAPEUTICS, INC.
Form 4 ZEVRA THERAPEUTICS, INC. For: Jan 30 Filed by: Quartel Adrian W
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.